Pharmatech Associates Conference Returns to Shanghai to Advise Chinese Firms on SFDA Regulatory Guidelines
Published: Dec 08, 2009
HAYWARD, Calif.--(BUSINESS WIRE)--Pharmatech Associates, consultants to the pharmaceutical, biotech and other regulated life sciences industries, is returning to Shanghai this week to host a new two-day conference for companies working in biotech, biomedical, bio pharma, and other regulated areas of the biological sciences. The conference (Dec 11-12) will focus on fundamental quality activities such as Root Cause Analysis (RCA) and Corrective Action / Preventive Action (CAPA) to help corporations achieve compliance with the new regulatory guidelines issued by the People’s Republic of China’s State Food and Drug Administration (SFDA). Attendees will learn about compliance with SFDA guidelines and their correlation with FDA / EMEA requirements in the United States and the European Union.